HM Payson & Co’s Mesoblast MESO Stock Holding History

HM Payson & Co’s Portfolio MESO Stock Details MESO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-25	Closed	–	–	1134
2021 Q3	$0	Hold	25	–	–	﹤0.01%	1111
2021 Q2	$0	Hold	25	–	–	﹤0.01%	1135
2021 Q1	$0	Hold	25	–	–	﹤0.01%	1157
2020 Q4	$0	Hold	25	–	–	﹤0.01%	1134
2020 Q3	$1K	Hold	25	–	–	﹤0.01%	1002
2020 Q2	$1K	Buy	+25	New	+$535	﹤0.01%	843

Other funds holding MESO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Penbrook Management New York $132M AUM 29.91% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

LCM

Lattice Capital Management Kirkland, Washington $56.9M AUM 49.15% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

HM Payson & Co's MESO Position: Q4 2021 in Review

HM Payson & Co sold out of Mesoblast (MESO) in Q4 2021, closing a stake of 25 shares.

HM Payson & Co first reported a position in MESO in Q2 2020 and held it in 6 quarters. The position peaked at $1K in Q3 2020. 42 funds tracked by Wall St. Rank hold MESO as of Q4 2021.

HM Payson & Co reported no remaining Mesoblast position as of Q4 2021 after selling out during the quarter.
HM Payson & Co sold 25 Mesoblast shares in Q4 2021.
HM Payson & Co first reported a position in Mesoblast in Q2 2020 and held it in 6 quarters.
HM Payson & Co's Mesoblast position peaked at $1K in Q3 2020.
42 funds tracked by Wall St. Rank held Mesoblast as of Q4 2021.

Based on HM Payson & Co's 13F filing for Q4 2021, filed 15 Feb 2022.